Lupin earns FDA approval for activella tablets

Lupin, a drug company headquartered in Mumbai, recently earned FDA approval for its Amabelz tablets.

Advertisement

Amabelz tablets are the generic equivalent of the brand name Activella tablets produced by Bridgewater, N.J.-based Amneal Pharmaceuticals. Amabelz tablets are intended to prevent postmenopausal osteoporosis, as well as treat symptoms caused by menopause including moderate to severe vasomotor symptoms and vaginal atrophy.

Last year, Activella had U.S. sales of $95.6 million.

More articles on supply chain:

As childhood diabetes rates rise, so do treatment costs: 5 things to know
One-third of cancer patients suffer financial hardship due to drug costs: 4 things to know
How Mayo Clinic is diversifying its suppliers

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.